JCVI advises UK government on gonorrhoea and mpox vaccinations
Both programmes will be offered to those most at risk of developing STIs
Read Moreby Jen Brogan | Nov 15, 2023 | News | 0
Both programmes will be offered to those most at risk of developing STIs
Read Moreby Jen Brogan | Nov 8, 2023 | News | 0
Zoliflodacin inhibits the vital bacterial enzyme for bacterial function and reproduction
Read Moreby Jen Brogan | Sep 22, 2023 | News | 0
The collaboration will utilise Evaxion’s EDEN-discovered antigen targets
Read Moreby Selina McKee | Sep 7, 2020 | News | 0
Almost 71,000 cases were diagnosed in 2019, prompting new warnings on the need to practice safe sex
Read Moreby Anna Smith | Jan 11, 2019 | News | 0
Two women in the UK have been infected with so-called super-gonorrhoea, amid an increase in antibiotic resistance.
Read Moreby Selina McKee | Jul 12, 2017 | News | 0
Researchers in New Zealand have found that teenagers given a meningitis B vaccine were significantly less likely to contract gonorrhoea, marking the first time a vaccine has shown any protection against the sexually transmitted infection (STI).
Read Moreby Selina McKee | Jul 12, 2017 | News | 0
Central government cuts have forced councils in England to cut their planned spend on vital public health services by £85 million, according to new analysis by The King’s Fund.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
